Is a complete BVS research report available?

No complete published report is available for Bioventus Inc. (BVS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Bioventus Inc. (BVS)

NASDAQ: BVS · USD

$14.6

+0.19 (+1.3%)· Recorded snapshot

Market cap	1.2B
Revenue (ttm)	581.8M
Net income (ttm)	54.5M
EPS (ttm)	$0.78
Shares out	84.1M
P/E (trailing)	18.7x
P/E (forward)	18.2x
Volume	507,264
Beta	0.64

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Metric	Value
Amount currency	USD
CIK code	0001665988
Company name	Bioventus Inc.
Country	United States
Country code	US
CUSIP number	09075A108
Earnings date	2026-11-02
Earnings time	amc
Employees	950
Employees change	0
Employees growth	0%
Enterprise value	$1.5B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-27
First seen	2026-05-09
Fiscal year end	December
Founded	2011
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2021-02-11
Is primary listing	Yes
Is SPAC	No
ISIN number	US09075A1088
Last 10-K release date	2026-03-05
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.2B
Market cap category	Small-Cap
Next earnings date	2026-11-02
Options	Yes
Price	$14.61
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	BVS
U.S. state	North Carolina
Website	https://www.bioventus.com

Metric

Value

Amount currency

USD

CIK code

0001665988

Company name

Bioventus Inc.

Country

United States

Country code

CUSIP number

09075A108

Earnings date

2026-11-02

Earnings time

amc

Employees

950

Employees change

Employees growth

Enterprise value

$1.5B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-27

First seen

2026-05-09

Fiscal year end

December

Founded

2011

In index

RUSSELL2000

Industry

Medical Devices

IPO date

2021-02-11

Is primary listing

Yes

Is SPAC

ISIN number

US09075A1088

Last 10-K release date

2026-03-05

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1.2B

Market cap category

Small-Cap

Next earnings date

2026-11-02

Options

Yes

Price

$14.61

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

BVS

U.S. state

North Carolina

Website

https://www.bioventus.com

Metric	Value
Adjusted P/E ratio	19.22x
Earnings yield	5.35%
EV/Earnings	26.67x
EV/EBIT	23.97x
EV/EBITDA	18.13x
EV/FCF	15.41x
EV/Sales	2.5x
FCF / EV yield	6.49%
FCF yield	7.73%
Forward EV/Sales	2.33x
Forward P/E	18.19x
Forward P/S	1.96x
Graham number	7.67471
Graham upside	-47.07%
Industry forward P/E	19.81x
Industry P/E	39.5x
Lynch fair value	$19.55
Lynch upside	34.85%
P/(FCF - SBC) ratio	15.36x
P/(OCF - SBC) ratio	14.88x
P/B ratio	4.31x
P/E ratio	18.68x
P/FCF ratio	12.93x
P/OCF ratio	12.59x
P/S ratio	2.1x
PEG ratio	1.64x
Price/EBITDA ratio	15.21x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

19.22x

Earnings yield

5.35%

EV/Earnings

26.67x

EV/EBIT

23.97x

EV/EBITDA

18.13x

EV/FCF

15.41x

EV/Sales

2.5x

FCF / EV yield

6.49%

FCF yield

7.73%

Forward EV/Sales

2.33x

Forward P/E

18.19x

Forward P/S

1.96x

Graham number

7.67471

Graham upside

-47.07%

Industry forward P/E

19.81x

Industry P/E

39.5x

Lynch fair value

$19.55

Lynch upside

34.85%

P/(FCF - SBC) ratio

15.36x

P/(OCF - SBC) ratio

14.88x

P/B ratio

4.31x

P/E ratio

18.68x

P/FCF ratio

12.93x

P/OCF ratio

12.59x

P/S ratio

2.1x

PEG ratio

1.64x

Price/EBITDA ratio

15.21x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	10.42%
EBITDA margin	13.77%
FCF margin	16.2%
Gross margin	68.65%
Operating margin	10.42%
Pretax margin	6.64%
Profit margin	9.36%
Profit per employee	$57,331
Profitable quarters	5
Profitable years	1
Revenue per employee	$612,472
ROA	5.49%
ROA (5Y)	1.59%
ROCE	11.64%
ROE	25.68%
ROE (5Y)	-15.09%
ROIC	12.15%
ROIC (5Y)	3.59%
SBC / revenue	2.56%
Tax / revenue	-3.92%

Metric

Value

EBIT margin

10.42%

EBITDA margin

13.77%

FCF margin

16.2%

Gross margin

68.65%

Operating margin

10.42%

Pretax margin

6.64%

Profit margin

9.36%

Profit per employee

$57,331

Profitable quarters

Profitable years

Revenue per employee

$612,472

ROA

5.49%

ROA (5Y)

1.59%

ROCE

11.64%

ROE

25.68%

ROE (5Y)

-15.09%

ROIC

12.15%

ROIC (5Y)

3.59%

SBC / revenue

2.56%

Tax / revenue

-3.92%

Metric	Value
EPS growth (Q)	327.28%
EPS growth (QoQ)	1,075%
EPS growth 5Y	24.66%
EPS growth quarters	2
EPS growth years	3
FCF growth	176.52%
FCF growth (Q)	-25.11%
FCF growth (QoQ)	126.23%
FCF growth 3Y	129.31%
FCF growth 5Y	18.77%
Gross profit growth	4.74%
Gross profit growth (Q)	3.5%
Gross profit growth 3Y	7.47%
Gross profit growth 5Y	8%
Net income growth (Q)	348.33%
Net income growth (QoQ)	974.24%
Net income growth 5Y	55.11%
Net income growth quarters	8
Net income growth years	3
OCF growth	167.27%
OCF growth (Q)	-23.38%
OCF growth (QoQ)	122.44%
OCF growth 3Y	75.81%
OCF growth 5Y	16.28%
Operating income growth	50.05%
Operating income growth (Q)	1.91%
Operating income growth 5Y	11%
Revenue growth	3.14%
Revenue growth (Q)	3.76%
Revenue growth (QoQ)	15.99%
Revenue growth 3Y	4.45%
Revenue growth 5Y	9.12%
Revenue growth quarters	3
Revenue growth years	0

Metric

Value

EPS growth (Q)

327.28%

EPS growth (QoQ)

1,075%

EPS growth 5Y

24.66%

EPS growth quarters

EPS growth years

FCF growth

176.52%

FCF growth (Q)

-25.11%

FCF growth (QoQ)

126.23%

FCF growth 3Y

129.31%

FCF growth 5Y

18.77%

Gross profit growth

4.74%

Gross profit growth (Q)

3.5%

Gross profit growth 3Y

7.47%

Gross profit growth 5Y

Net income growth (Q)

348.33%

Net income growth (QoQ)

974.24%

Net income growth 5Y

55.11%

Net income growth quarters

Net income growth years

OCF growth

167.27%

OCF growth (Q)

-23.38%

OCF growth (QoQ)

122.44%

OCF growth 3Y

75.81%

OCF growth 5Y

16.28%

Operating income growth

50.05%

Operating income growth (Q)

1.91%

Operating income growth 5Y

11%

Revenue growth

3.14%

Revenue growth (Q)

3.76%

Revenue growth (QoQ)

15.99%

Revenue growth 3Y

4.45%

Revenue growth 5Y

9.12%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-2.6M
Depreciation and amortization	$19.5M
EBIT	$60.6M
EBITDA	$80.1M
EPS	$0.78
FCF per share	$1.12
Financing cash flow	$-95M
Free cash flow	$94.3M
Free cash flow minus SBC	$79.4M
Gross profit	$399.4M
Income taxes	$-22.8M
Investing cash flow	$-4.1M
Net borrowing	$-27.9M
Net cash flow	$-3.5M
Net income	$54.5M
Operating cash flow minus SBC	$82M
Operating income	$60.6M
Revenue	$581.8M
Stock-based compensation	$14.9M

Metric

Value

Capital expenditures

$-2.6M

Depreciation and amortization

$19.5M

EBIT

$60.6M

EBITDA

$80.1M

EPS

$0.78

FCF per share

$1.12

Financing cash flow

$-95M

Free cash flow

$94.3M

Free cash flow minus SBC

$79.4M

Gross profit

$399.4M

Income taxes

$-22.8M

Investing cash flow

$-4.1M

Net borrowing

$-27.9M

Net cash flow

$-3.5M

Net income

$54.5M

Operating cash flow minus SBC

$82M

Operating income

$60.6M

Revenue

$581.8M

Stock-based compensation

$14.9M

Metric	Value
Altman Z-Score	1.54
Book value per share	$3.35
Debt / EBITDA	3.08
Debt / equity	0.95
Debt / FCF	2.8
Goodwill	$7.5M
Interest coverage	3.05
Long-term assets	$415.8M
Long-term liabilities	$243.5M
Net cash (debt)	$-233.4M
Net cash / market cap	-19.14%
Net debt / EBITDA	2.91
Net debt / equity	0.84
Net debt / FCF	2.47
Piotroski F-Score	8
Property, plant and equipment	$24.8M
Shareholders' equity	$277.4M
Tangible book value	$-130.2M
Tangible book value per share	$-1.91
Total assets	$673.3M
Total cash	$30.4M
Total debt	$263.7M
Total liabilities	$395.9M
WACC	7.46%

Metric

Value

Altman Z-Score

1.54

Book value per share

$3.35

Debt / EBITDA

3.08

Debt / equity

0.95

Debt / FCF

2.8

Goodwill

$7.5M

Interest coverage

3.05

Long-term assets

$415.8M

Long-term liabilities

$243.5M

Net cash (debt)

$-233.4M

Net cash / market cap

-19.14%

Net debt / EBITDA

2.91

Net debt / equity

0.84

Net debt / FCF

2.47

Piotroski F-Score

Property, plant and equipment

$24.8M

Shareholders' equity

$277.4M

Tangible book value

$-130.2M

Tangible book value per share

$-1.91

Total assets

$673.3M

Total cash

$30.4M

Total debt

$263.7M

Total liabilities

$395.9M

WACC

7.46%

Metric	Value
Asset turnover	0.84
Current assets	$257.5M
Current liabilities	$152.5M
Current ratio	1.69
Inventory turnover	2.07
Net working capital	$97.6M
Quick ratio	1.11
Working capital	$105.1M
Working capital turnover	5.98

Metric

Value

Asset turnover

0.84

Current assets

$257.5M

Current liabilities

$152.5M

Current ratio

1.69

Inventory turnover

2.07

Net working capital

$97.6M

Quick ratio

1.11

Working capital

$105.1M

Working capital turnover

5.98

Metric	Value
Buyback yield / dilution	-5.97%
Dividend yield	0%
Shareholder yield	-5.97%

Metric

Value

Buyback yield / dilution

-5.97%

Dividend yield

Shareholder yield

-5.97%

Metric	Value
150-day SMA	$11.64
1D price change	1.32%
1M price change	5.07%
1M total return	5.07%
1W price change	4.01%
1W total return	4.01%
1Y price change	116.24%
1Y return CAGR	116.36%
1Y total return	116.24%
20-day SMA	$13.74
200-day SMA	$10.84
3M price change	16.55%
3M total return	16.55%
3Y price change	341.03%
3Y return CAGR	63.97%
3Y total return	341.03%
50-day SMA	$13.72
50-day SMA vs 200-day SMA	50over200
52-week high	$15.89
52-week high date	2026-08-05
52-week low	$6.47
52-week low date	2025-11-21
5Y price change	-3.14%
5Y return CAGR	-0.64%
5Y total return	-3.14%
6M price change	44.96%
6M total return	44.96%
All-time high	$19.94
All-time high date	2021-06-28
All-time low	$0.80
All-time low date	2023-03-31
Average true range (ATR)	$0.52
Average volume	386.8K
Beta (1Y)	0.58
Beta (2Y)	0.54
Beta (5Y)	0.64
Change from 52-week high	-8.07%
Change from 52-week low	125.81%
Change from all-time high	-27.24%
Change from all-time low	1,713.98%
Change from open	1.32%
Day's gap	0%
Dollar volume	$7.4M
High price	$14.74
Low price	$14.42
Monthly RSI	69.91
Open price	$14.42
Position in 52-week range	59.37%
Premarket change	-1.04%
Premarket close	$14.42
Premarket price	$14.27
Previous close	$14.42
Price vs 150-day SMA	24.67%
Price vs 20-day SMA	5.62%
Price vs 200-day SMA	33.89%
Price vs 50-day SMA	5.77%
Relative volume	1.31
Return from IPO open	-3.97%
Return from IPO price	11.54%
RSI	58.57
Sharpe ratio	1.69
Sharpe ratio (3Y)	1.08
Sharpe ratio (5Y)	0.38
Sortino ratio	2.92
Sortino ratio (3Y)	1.96
Sortino ratio (5Y)	0.64
Volume	507.3K
Weekly RSI	64.76
YTD price change	95.03%
YTD total return	95.03%

Metric

Value

150-day SMA

$11.64

1D price change

1.32%

1M price change

5.07%

1M total return

5.07%

1W price change

4.01%

1W total return

4.01%

1Y price change

116.24%

1Y return CAGR

116.36%

1Y total return

116.24%

20-day SMA

$13.74

200-day SMA

$10.84

3M price change

16.55%

3M total return

16.55%

3Y price change

341.03%

3Y return CAGR

63.97%

3Y total return

341.03%

50-day SMA

$13.72

50-day SMA vs 200-day SMA

50over200

52-week high

$15.89

52-week high date

2026-08-05

52-week low

$6.47

52-week low date

2025-11-21

5Y price change

-3.14%

5Y return CAGR

-0.64%

5Y total return

-3.14%

6M price change

44.96%

6M total return

44.96%

All-time high

$19.94

All-time high date

2021-06-28

All-time low

$0.80

All-time low date

2023-03-31

Average true range (ATR)

$0.52

Average volume

386.8K

Beta (1Y)

0.58

Beta (2Y)

0.54

Beta (5Y)

0.64

Change from 52-week high

-8.07%

Change from 52-week low

125.81%

Change from all-time high

-27.24%

Change from all-time low

1,713.98%

Change from open

1.32%

Day's gap

Dollar volume

$7.4M

High price

$14.74

Low price

$14.42

Monthly RSI

69.91

Open price

$14.42

Position in 52-week range

59.37%

Premarket change

-1.04%

Premarket close

$14.42

Premarket price

$14.27

Previous close

$14.42

Price vs 150-day SMA

24.67%

Price vs 20-day SMA

5.62%

Price vs 200-day SMA

33.89%

Price vs 50-day SMA

5.77%

Relative volume

1.31

Return from IPO open

-3.97%

Return from IPO price

11.54%

RSI

58.57

Sharpe ratio

1.69

Sharpe ratio (3Y)

1.08

Sharpe ratio (5Y)

0.38

Sortino ratio

2.92

Sortino ratio (3Y)

1.96

Sortino ratio (5Y)

0.64

Volume

507.3K

Weekly RSI

64.76

YTD price change

95.03%

YTD total return

95.03%

Metric	Value
Float	34.3M
Float percentage	40.79%
Shares change (QoQ)	1.19%
Shares change (YoY)	5.97%
Shares held by insiders	2.64%
Shares held by institutions	44.2%
Shares outstanding	84.1M
Short % of float	9.27%
Short % of shares	3.78%
Short ratio	6.3 days

Metric

Value

Float

34.3M

Float percentage

40.79%

Shares change (QoQ)

1.19%

Shares change (YoY)

5.97%

Shares held by insiders

2.64%

Shares held by institutions

44.2%

Shares outstanding

84.1M

Short % of float

9.27%

Short % of shares

3.78%

Short ratio

6.3 days

Bioventus Inc. (BVS)

Price

Financial snapshot

Fair-value bridge

Latest news · BVS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVS

Frequently asked questions